{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_aflibercept",
          "name": "Aflibercept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_copanlisib",
          "name": "Copanlisib"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_belimumab",
          "name": "Belimumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sunitinib",
          "name": "Sunitinib"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [],
    "ranking": [],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aflibercept",
          "type": "Drug",
          "label": "Aflibercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_copanlisib",
          "type": "Drug",
          "label": "Copanlisib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sunitinib",
          "type": "Drug",
          "label": "Sunitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_complement",
          "type": "Target",
          "label": "Complement System",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_a_hus",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_aflibercept",
          "type": "Drug",
          "label": "Aflibercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_copanlisib",
          "type": "Drug",
          "label": "Copanlisib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_sunitinib",
          "type": "Drug",
          "label": "Sunitinib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot",
          "type": "Target",
          "label": "OffTarget",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "RiskPathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "AdversePhenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Aflibercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Copanlisib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Belimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Sunitinib",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "n_target_complement",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知机制通过抑制补体系统"
        },
        {
          "source": "drug_ravulizumab",
          "target": "n_target_complement",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "与 Eculizumab 共享相似作用机制"
        },
        {
          "source": "drug_aflibercept",
          "target": "n_pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "抗炎作用对 HUS 表型的潜在影响"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "常用于调节免疫反应"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "n_pathway_inflammatory_response",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通过清除炎症因子"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "慢性免疫疾病中的用药"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "n_pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于免疫介导的疾病"
        },
        {
          "source": "drug_tacrolimus",
          "target": "n_pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "免疫抑制效应"
        },
        {
          "source": "drug_copanlisib",
          "target": "n_pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "抑制 B 细胞活性"
        },
        {
          "source": "drug_rituximab",
          "target": "n_pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "IgG 的作用机制支持"
        },
        {
          "source": "drug_belimumab",
          "target": "n_pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "已知对自身免疫性疾病的调节"
        },
        {
          "source": "drug_sunitinib",
          "target": "n_pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "偶联良好，但不直接关联"
        },
        {
          "source": "n_target_complement",
          "target": "d_a_hus",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "补体系统直接关联 HUS"
        },
        {
          "source": "n_pathway_inflammatory_response",
          "target": "d_a_hus",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "炎症反应影响 HUS 表型"
        },
        {
          "source": "drug_eculizumab",
          "target": "H1",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知用于 HUS 的治疗"
        },
        {
          "source": "drug_ravulizumab",
          "target": "H2",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与 Eculizumab 的相似性支撑"
        },
        {
          "source": "drug_aflibercept",
          "target": "H3",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "可能的辅助疗法"
        },
        {
          "source": "drug_corticosteroids",
          "target": "H4",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已用于相关的免疫性疾病"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "H5",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有益于症状的缓解"
        },
        {
          "source": "drug_methotrexate",
          "target": "H6",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "在免疫干预中可用"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "H7",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可能的疗法选项"
        },
        {
          "source": "drug_tacrolimus",
          "target": "H8",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "在特定患者中可考虑"
        },
        {
          "source": "drug_copanlisib",
          "target": "H9",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "潜在的研究支持"
        },
        {
          "source": "drug_rituximab",
          "target": "H10",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已用于自身免疫性相关疾病"
        },
        {
          "source": "drug_belimumab",
          "target": "H11",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "有文献支持其抗炎作用"
        },
        {
          "source": "drug_sunitinib",
          "target": "H12",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "在某些情况下获益"
        },
        {
          "source": "n_eculizumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ravulizumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "促生物标志物变化可能影响疗效"
        },
        {
          "source": "n_aflibercept",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "靶向路径可能存在干扰"
        },
        {
          "source": "n_corticosteroids",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能导致免疫抑制，增加感染风险"
        },
        {
          "source": "n_plasmapheresis",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "疗效依赖于适用性"
        },
        {
          "source": "n_methotrexate",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "多种机制可能导致副作用"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Skeptic",
          "rationale": "诱导的毒性可能显著"
        },
        {
          "source": "n_tacrolimus",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Skeptic",
          "rationale": "可能导致长期免疫问题"
        },
        {
          "source": "n_copanlisib",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Skeptic",
          "rationale": "潜在副作用需关注"
        },
        {
          "source": "n_rituximab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Skeptic",
          "rationale": "有关免疫不良影响的担忧"
        },
        {
          "source": "n_belimumab",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Skeptic",
          "rationale": "需验证相关性与疗效"
        },
        {
          "source": "n_sunitinib",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Skeptic",
          "rationale": "代谢涉及复杂性与毒性"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联复杂的风险机制"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "产生特定不良表型的风险"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若这些风险成立，将对H1的基本假设构成挑战"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险链存在，将削弱H2支持"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "不良反应可能限制H3的疗效"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "副作用可能导致与其它假设冲突"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的反向作用影响H5有效性"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "需考虑长期风险影响H6"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "与疗效的对比存在潜在问题"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "对H8的支持可能会遭到挑战"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能存在毒性风险影响H9"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "不良表型将影响H10的疗效"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在的不良反应可能对H11的应用产生影响"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "H12可能会受到不良反应的干扰"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "score": 0.78,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Eculizumab 可有效抑制补体系统",
          "补体系统对 HUS 具有直接影响"
        ],
        "caveats": [
          "潜在不良副作用影响疗效",
          "需要进一步的长期安全性研究"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "score": 0.75,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "Ravulizumab 与 Eculizumab 共享相似机制",
          "可用于 HUS 相关的治疗"
        ],
        "caveats": [
          "尚无充分临床数据支持",
          "副作用需更多关注"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_aflibercept",
          "name": "Aflibercept"
        },
        "score": 0.68,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "具有一定的抗炎作用",
          "可能作为辅助治疗"
        ],
        "caveats": [
          "疗效的不确定性",
          "需更多随机对照试验验证"
        ],
        "confidence": "medium-low"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target (Complement System)→Disease (Atypical Haemolytic Uraemic Syndrome)",
          "reason": "Eculizumab 和 Ravulizumab 以明确的机制路径证实对 HUS 的作用"
        }
      ],
      "remaining_gaps": [
        "副作用相关文献和数据支持尚不全面",
        "缺乏平行对照研究"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": [
        "维持机制解锁与多样性，确保新候选能有辨识度"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "强调需要更多数据以支持每种治疗方案的疗效与安全性"
      },
      {
        "role": "Skeptic",
        "patch": "确保每种假设均基于细致的安全性和疗效数据"
      }
    ],
    "heuristics": [
      {
        "when": "评估补体抑制药物",
        "then": "需额外关注长期使用后的输入效果与不良反应"
      }
    ]
  }
}